학술논문

EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations
Document Type
Academic Journal
Source
Orphanet Journal of Rare Diseases. February 13, 2014, Vol. 9
Subject
Nucleotide sequencing -- Analysis -- Research -- Health aspects -- Genetic aspects
Gene mutations -- Analysis -- Genetic aspects -- Health aspects -- Research
Genetic research -- Analysis -- Health aspects -- Genetic aspects
Nervous system diseases -- Genetic aspects -- Analysis -- Risk factors -- Research
DNA sequencing -- Analysis -- Research -- Health aspects -- Genetic aspects
Pregnant women -- Analysis -- Research -- Health aspects
Language
English
ISSN
1750-1172
Abstract
Background Pontocerebellar hypoplasia (PCH) represents a group of neurodegenerative disorders with prenatal onset. Eight subtypes have been described thus far (PCH1-8) based on clinical and genetic features. Common characteristics include hypoplasia and atrophy of the cerebellum, variable pontine atrophy, and severe mental and motor impairments. PCH1 is distinctly characterized by the combination with degeneration of spinal motor neurons. Recently, mutations in the exosome component 3 gene (EXOSC3) have been identified in approximately half of the patients with PCH subtype 1. Methods We selected a cohort of 99 PCH patients (90 families) tested negative for mutations in the TSEN genes, RARS2, VRK1 and CASK. Patients in this cohort were referred with a tentative diagnose PCH type 1, 2, 4, 7 or unclassified PCH. Genetic analysis of the EXOSC3 gene was performed using Sanger sequencing. Clinical data, MR images and autopsy reports of patients positive for EXOSC3 mutations were analyzed. Results EXOSC3 mutations were found in twelve families with PCH subtype 1, and were not found in patients with other PCH subtypes. Identified mutations included a large deletion, nonsense and missense mutations. Examination of clinical data reveals a prolonged disease course in patients with a homozygous p.D132A mutation. MRI shows variable pontine hypoplasia in EXOSC3 mediated PCH, where the pons is largely preserved in patients with a homozygous p.D132A mutation, but attenuated in patients with other mutations. Additionally, bilateral cerebellar cysts were found in patients compound heterozygous for a p.D132A mutation and a nonsense allele. Conclusions EXOSC3 mediated PCH shows clear genotype-phenotype correlations. A homozygous p.D132A mutation leads to PCH with possible survival into early puberty, and preservation of the pons. Compound heterozygosity for a p.D132A mutation and a nonsense or p.Y109N allele, a homozygous p.G31A mutation or a p.G135E mutation causes a more rapidly progressive course leading to death in infancy and attenuation of the ventral pons. Our findings imply a clear correlation between genetic mutation and clinical outcome in EXOSC3 mediated PCH, including variable involvement of the pons. Keywords: Pontocerebellar hypoplasia, Neurodegeneration, EXOSC3 gene, Genotype-phenotype correlations
Author(s): Veerle RC Eggens[sup.1] , Peter G Barth[sup.2] , Jikke-Mien F Niermeijer[sup.2] , Jonathan N Berg[sup.3] , Niklas Darin[sup.4] , Abhijit Dixit[sup.5] , Joel Fluss[sup.6] , Nicola Foulds[sup.7] , Darren [...]